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Abstract 
The aim of this article is to analyze the vascular dysfunctions occurring after spinal cord injury (SCI). Vascular dysfunctions 
are common complications of SCI. Cardiovascular disturbances are the leading causes of morbidity and mortality in both acute and 
chronic stages of SCI. 
Neuroanatomy and physiology of autonomic nervous system, sympathetic and parasympathetic, is reviewed.  
SCI implies disruption of descendent pathways from central centers to spinal sympathetic neurons, originating in 
intermediolateral nuclei of T1-L2 cord segments.  Loss of supraspinal control over sympathetic nervous system results in reduced 
overall sympathetic activity below the level of injury and unopposed parasympathetic outflow through intact vagal nerve.  
SCI associates significant vascular dysfunction. Spinal shock occurs during the acute phase following SCI and it is a 
transitory suspension of function and reflexes below the level of the injury. Neurogenic shock, part of spinal shock, consists of severe 
arterial hypotension and bradycardia. Autonomic dysreflexia appears during the chronic phase, after spinal shock resolution, and it is 
a life-threatening syndrome of massive imbalanced reflex sympathetic discharge occurring in patients with SCI above the splanchnic 
sympathetic outflow (T5-T6). Arterial hypotension with orthostatic hypotension occurs in both acute and chronic phases. The etiology 
is multifactorial. We described a few factors influencing the orthostatic hypotension occurrence in SCI: sympathetic nervous system 
dysfunction, low plasma catecholamine levels, rennin-angiotensin-aldosterone activity, peripheral alpha-adrenoceptor 
hyperresponsiveness, impaired function of baroreceptors, hyponatremia and low plasmatic volume, cardiovascular deconditioning, 
morphologic changes in sympathetic neurons, plasticity within spinal circuits, and motor deficit leading to loss of skeletal muscle 
pumping activity. Additional associated cardiovascular concerns in SCI, such as deep vein thrombosis and long-term risk for 
coronary heart disease and systemic atherosclerosis are also described.   
Proper prophylaxis, including non-pharmacologic and pharmacological strategies, diminishes the occurrence of the 
vascular dysfunction following SCI. Each vascular disturbance requires a specific treatment.  
 
Keywords: spinal shock, neurogenic shock, orthostatic hypotension,  
autonomic dysreflexia, deep vein thrombosis, coronary heart disease.  
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Spinal cord injury (SCI) is one of most important 
health problems worldwide, and one of the most 
devastating of all traumatic events, with an annual 
incidence of 15 to 52.5 cases per million of population. 
About 80% are young males, aged between 15 and 35 
years, and 5% are children.1-6 Neurological disability is 
frequently encountered, from all spinal cord injured 
patients 53% are tetraplegic and 42% are paraplegic. 
The aim of this article is to evaluate the vascular 
dysfunctions following SCI. Vascular dysfunctions are 
common consequences of SCI, and are issues of interest 
worldwide. Cardiovascular disturbances are the leading 
causes of morbidity and mortality in both acute and 
chronic stages of SCI.7-9  
Impairment in control of the autonomic nervous 
system, mostly in patients with cervical and high thoracic 
SCI, causes arterial hypotension, bradycardia, and 
autonomic dysreflexia. Besides, additional vascular 
complications, such as deep vein thrombosis and long-
term risk for coronary heart disease and systemic 
atherosclerosis, may occur.  Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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Epidemiology 
SCI causes important cardiovascular 
disturbances, with short and long term consequences.6  
An adequate treatment of the cardiovascular disturbances 
pays an important role in the therapeutic management of 
SCI. By reducing the incidence of cardiovascular 
pathology, morbidity and mortality rates diminish and the 
quality of life in patients with SCI improves. 
Cardiovascular disturbances are the most common 
underlying cause of death, after neoplasms,  in 21.6% 
cases, and they are contributing causes of death in 18.9% 
of the cases in chronic SCI.8 Cardiovascular dysfunctions 
contribute to 40.5% of the deaths, when both underlying 
and contributing causes.8  The most common causes of 
death are cardiac failure, atrial fibrillation, atherosclerosis 
and coronary heart disease, ventricular tachycardia, 
rupture of abdominal aneurysm, cerebrovascular disease, 
cardiac arrest, cardiomyopathy and ill-defined heart 
disease.8  
All the patients with motor complete cervical SCI 
(ASIA A and B) develop bradycardia, 68% develop arterial 
hypotension, 35% of the patients require vasopressors, 
and cardiac arrest occurs in 16% of them.6,10 From 
patients with motor incomplete cervical SCI (ASIA C and 
D), 35-71% develop bradycardia, but few have 
hypotension and require vasopressors.6 Very rarely they 
develop cardiac arrest.6 Thoracolumbar SCI bradycardia 
is encountered in 13-35% cases.6  
The prevalence of autonomic dysreflexia is 48-
90% of SCI above T6.11-13 
Deep vein thrombosis occurs in 47-90% cases.6 
Proximal progression of thrombosis and pulmonary 
embolism appears in 20-50% of cases.6 Pulmonary 
embolism causes 35% of deaths.6   
Coronary heart disease and systemic 
atherosclerosis are common findings in patients with 
chronic SCI, due to the lack of physical activity, obesity, 
hiperlipidemia, insulin resistance and diabetes, which are 
more frequently encountered in this group than in the 
general population.6  
Neuroanatomy  
Insula, medial prefrontal cortex, hypothalamus, 
and cuneiform nucleus project into cardiovascular nuclei 
within medulla oblongata.14-16 Parasympathetic impulses 
are carried out via the vagus nerve. Preganglionic fibers 
synapse with postganglionic parasympathetic neurons are 
near the myocardium. There is no parasympathetic 
outflow for peripheral vessels.  
The preganglionic sympathetic neurons are 
located within the lateral horn into the intermediolateral 
nuclei of T1-L2 cord segments. They exit the spinal cord 
via the ventral root, and synapse with postganglionic 
neurons from paravertebral sympathetic chain. 
Postganglionic sympathetic fibers outflow through 
peripheral nerves vessels and heart.  
Pathophysiology  
Besides the well-known motor and sensitive 
deficits, autonomic disturbances are frequently 
encountered. Autonomic nervous system pays a highly 
important role in the cardiovascular control. Blood 
pressure and heart rate are controlled by impulses from 
the autonomic nervous system: sympathetic and 
parasympathetic. They act antagonistically, according to 
various needs. The parasympathetic decreases the heart 
rate. The sympathetic increases the heart rate, myocardic 
contractibility, raises peripheral vascular resistance and 
the arterial blood pressure, by inducing vasoconstriction. 
The arterial blood pressure control depends on the activity 
of the supraspinal centers, which send activator impulses, 
through descendent pathways, to sympathetic spinal 
preganglionar neurons. Secondary to SCI, descendent 
pathways are interrupted and spinal circuits become 
incapable to generate sympathetic activity. Disruption of 
descendent pathways results in sympathetic hypoactivity 
and unopposed parasympathetic outflow through the 
intact vagal nerve. Sympathetic hypoactivity results in low 
resting blood pressure, loss of regular adaptability of 
blood pressure, and disturbed reflex control.  
Vascular dysfunctions following SCI 
The spinal shock with the neurogenic shock 
represent a vascular dysfunction that occurs during the 
acute phase of SCI. Autonomic dysreflexia, coronary 
heart disease and systemic atherosclerosis are 
encountered during the chronic phase of SCI. Arterial 
hypotension and deep vein thrombosis are found in both 
acute and chronic periods of time.  
 
A.  Vascular dysfunctions during the acute phase of 
SCI 
The initial response to SCI is a massive 
sympathetic stimulation and reflex parasympathetic 
activity that usually lasts for 3 to 4 minutes and it is 
mediated by alpha-adrenergic receptors. The 
hemodynamic effects are severe hypertension and reflex 
bradycardia or tachyarrhythmia. The massive sympathetic 
stimulation is due to norepinephrine release from the 
suprarenal glands. There is also a pressor response 
caused by the disruption of the cervical and high thoracic 
vasoactive neurons.17 Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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Following this first phase, a massive decrease of 
sympathetic activity occurs, due to the disruption of 
descendent sympathetic tracts. The result is 
physiologically similar to spinal anesthesia and leads to 
cutaneous vasodilatation, venodilation and reduced 
venous return, low blood pressure, low cardiac output, 
bradycardia, bradyarrhythmias and atrioventricular nodal 
block, due to the lack of vasoconstrictor and inotrope 
sympathetic activity. The patient is prone to hypothermia, 
arterial hypotension and bradycardia, by the absence of 
sympathetic tone and unopposed vagal tone.  
Following this brief hypertensive peak, spinal 
shock occurs.  
 
Spinal shock 
The spinal shock is a physiological disruption of 
the spinal cord functioning that accompanies SCI. It is a 
transitory suspension of function and reflexes below the 
level of the injury. Inputs from autonomic central centers 
modulate the activity of sympathetic spinal neurons. 
Sudden disruption of communication between these 
centers and the sympathetic neurons in the 
intermediolateral thoracic and lumbar spinal cord leads to 
spinal shock. 
Spinal shock was described for the first time by 
Whytt in 1750, and the term “spinal shock” was later 
introduced in the literature by Hall in 1841.18 The spinal 
shock’s characteristics are sensory deficits, flaccid 
paralysis, absence of deep tendon reflexes, abolishment 
of reflex somatic activity, and thermoregulatory 
disturbances below the level of injury. The spinal shock 
etiology and pathogenesis remain controversial. 
Nowadays, there are different theories that partially 
explain the phenomenon.18,19 Spinal shock involves 
different aspects according to the site of the cord injury. In 
high cervical SCI, some of the following occur: acute 
respiratory failure, tetraplegia, anesthesia, lack of all 
reflexes below injury site, neurogenic shock, detrusor and 
rectum areflexia, ipsilateral Horner syndrome (ptosis, 
enophthalmos, miosis, anhidrosis). In low cervical SCI, 
there is no respiratory failure, because the respiratory 
muscles are not affected. Patients with high thoracic SCI 
develop paraparesis. In low thoracic injuries there is no 
arterial hypotension and no neurogenic shock.20   
Neurogenic shock consists of severe arterial 
hypotension, bradycardia and hypotermia.20-23  It is a 
manifestation of the malfunction of the autonomic nervous 
system, and it is caused by the absence of sympathetic 
activity, through loss of supraspinal control and 
unopposed parasympathetic tone via the intact vagus 
nerve.21-24 Systolic blood pressure below 90 mmHg in 
supine position, which is not the result of low intravascular 
volume due to hemorrhage or dehydration, is 
characteristic for neurogenic shock. Severe arterial 
hypotension usually requires vasopressors.21,22,25 Severity 
of arterial hypotension and the need for vasopressors are 
directly proportional with the severity of the injury.26 
Peripheral vascular resistance and cardiac output 
deceases, while central venous pressure remains 
unchanged.17  
The spinal shock usually lasts for days-weeks, 
the average being of 4-12 weeks.18,20-22,25,27,27-30 There is a 
lack of consensus on clinical signs, that defines the 
duration of spinal shock. The appearance of the 
bulbocavernosus reflex, recovery of deep tendon reflexes 
or return of reflex detrusor functions are considered by 
different authors the ending of the spinal shock. Ditunno 
et al. believe that spinal shock consists of four phases: 
areflexia or hyporeflexia (0-24 hours), initial reflex return 
(1-3 days), early hyperreflexia (4 days-1 month) and 
spasticity (1-12 months).31 
Neurogenic shock should not be mistaken with 
hypovolemic shock. In neurogenic shock, hypotension is 
associated with bradycardia, while in hypovolemic shock 
tachycardia occurs. In neurogenic shock, the skin is 
usually warm and dry, except for patients exposed to a 
cold environment. Neurogenic and hypovolemic shock 
may coexist, and when this happens, neurogenic shock 
exacerbates the effects of hypovolemic shock by disabling 
the vasoconstrictive reflexes that ordinarily preserve blood 
flow to vital organs.  
 
B.  Vascular dysfunctions that occur in both acute 
and chronic phase of SCI 
 
Arterial hypotension 
The abolished compensatory vasoconstriction, 
secondary to changes in sympathetic activity, especially 
into large vascular beds, like skeletal muscle and 
splanchnic region vessels, in association with reduced 
venous blood return, contribute to low blood pressure. 
Arterial hypotension, especially orthostatic hypotension, 
improves within days-weeks, thanks to the appearance of 
compensatory mechanisms involving the vascular bed, 
skeletal muscles activity, spasticity, increase in the 
muscular tone, reappearance of spinal sympathetic 
reflexes, and rennin-angiotensin-aldosterone system.6 
Arterial hypotension is common in both recent injuries, the 
mean resting blood pressure in tetraplegic patients is of 
81 mmHg, and in the chronic tetraplegics, the mean 
resting blood pressure is of 73 mmHg.32 
 
Orthostatic hypotension  
Orthostatic hypotension is very difficult to control, 
and severely impairs the quality of life.7 Orthostatic 
hypotension is common following cervical and high 
thoracic SCI.7,21,25,33,34 Patients with tetraplegia had a 
higher prevalence of orthostatic hypotension and a 
greater fall in blood pressure than patients with 
paraplegia, irrespective of whether their lesion was 
complete or incomplete.7,34 It is found in 73.6% of SCI 
patients, and 58.9% of them have symptoms, such as Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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light-headedness or dizziness.34 The incidence and 
severity of orthostatic hypotension diminishes in time.  
The Consensus Committee of the American 
Autonomic Society and the American Academy of 
Neurology Orthostatic established in 1996 that 
hypotension is a decrease in the systolic blood pressure 
of 20 mmHg or more, or a decrease in the diastolic blood 
pressure of 10 mmHg or more; this being based upon the 
assumption of an upright posture from a supine position, 
regardless of whether symptoms occur.35 
From clinical point of view, the orthostatic 
hypotension can be symptomatic, the patients 
experiencing dizziness, light-headedness, headache, 
fatigability, nausea, faint, pallor, sweating and loss of 
consciousness or it can lack any symptoms.  
 
Pathophysiology of orthostatic hypotension 
The disruption of efferent pathways from 
vasomotor center, located within the medulla oblongata, 
to spinal sympathetic neurons, originating into 
intermediolateral nuclei of T1-L2 segments involved in 
vasoconstriction, causes failure of blood pressure 
regulatory mechanisms and venous pooling.7,21,21,33,36 SCI 
associates significant sympathetic nervous system 
dysfunctions. This disturbance of sympathetic activity is 
the consequence of supraspinal control loss over the 
sympathetic nervous system. SCI with resultant 
tetraplegia or high paraplegia is associated with 
significant dysfunction of the sympathetic nervous system. 
Subsequent complications that occur below the level of 
SCI are reduced overall sympathetic activity, morphologic 
changes in sympathetic preganglionic neurons, and 
peripheral alpha-adrenoceptor hyperresponsiveness. 
Reduced sympathetic activity below the level of SCI, 
appears to result in orthostatic hypotension, low resting 
blood pressure, loss of diurnal fluctuation of blood 
pressure, reflex bradycardia, and, rarely, cardiac 
arrest.26,37 It is correlated with the severity of SCI. The 
incomplete SCI, which spare the dorsolateral cord, 
partially preserving the descending tonic sympathetic 
supraspinal control to spinal circuits, are less predisposal 
to low blood pressure.26 Severe disruption of the 
descending cardiovascular pathways is correlated with 
greater abnormalities of cardiovascular control.26,38  
The pathological mechanisms responsible for the 
orthostatic hypotension of SCI patients, still remain 
unclear. There are a few predisposal factors of 
occurrence of hypotension in SCI. The etiology of 
orthostatic hypotension is multifactorial. 
 
Factors influencing orthostatic hypotension 
occurrence in SCI:7 
1.  Sympathetic nervous system dysfunction 
2.  Low plasma catecholamine levels 
3.  Rennin-angiotensin-aldosterone activity 
4.  Peripheral alpha-adrenoceptor 
hyperresponsiveness  
5.  Impaired function of baroreceptors 
6.  Hyponatremia and low plasmatic volume 
7.  Cardiovascular deconditioning 
8.  Morphologic changes in sympathetic 
neurons 
9.  Plasticity within spinal circuits 
10.  Motor deficit leading to loss of skeletal 
muscle pumping activity 
 
1.  Sympathetic system dysfunction 
The sympathetic nervous system plays an 
important role in cardiovascular control. Sympathetic 
system dysfunction consists of the disruption of efferent 
pathways, with supraspinal control loss of spinal centers, 
both excitatory and inhibitory control with absent or 
decreased sympathetic tone below the injury level. 
The parasympathetic outflow is preserved, but 
the synergy between the parasympathetic and the 
sympathetic control is lost in patients with cervical or high 
thoracic SCI. SCI above T6 disrupt the supraspinal control 
and the sympathetic tone to the splanchnic vascular bed, 
predisposing the patient to orthostatic hypotension. In 
order to maintain the systemic blood pressure and the 
cerebral perfusion in orthostatism, systemic 
vasoconstriction is induced via an increase in the tonic 
sympathetic activity and the baroreceptor-mediated 
mechanisms. The disruption of efferent pathways from the 
brainstem cardiovascular center to the spinal sympathetic 
centers causes failure of short-term blood pressure 
regulation.7,21,33  
It depends on injury level. It is more severe in 
cervical or high thoracic, complete SCI.  
The dynamic test performed on SCI patients and 
normal individuals stresses the importance of the 
sympathetic nervous system dysfunction. 
Both the resting systolic and diastolic arterial 
pressures are lower in SCI patients than in normal 
individuals. Following the assumption of an upright seated 
position the SCI subject has a marked, progressive 
decrease in systolic and diastolic arterial pressure in the 
upright posture, the characteristic of the orthostatic 
hypotension, in contrast with normal individuals who have 
an increase in the systolic and diastolic arterial 
pressures.7 
The sympathetic vascular tone, assessed by the 
Mayer wave power spectrum of systolic blood pressure 
variability, increases significantly in response to 
orthostatic posture in patients with injuries below T4, but 
remains unchanged or decreases in patients with higher-
level injury.39 The systolic blood pressure significantly falls 
with postural shift in high-level injury group, and does not 
change in the low-level injury group.39 The low frequency 
component in the systolic blood pressure variability is lost 
in tetraplegic patients, comparative with normal 
individuals.40 Cervical spinal sympathetic pathways are Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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instrumental in the genesis of the Mayer waves. SCI 
interrupt spinal pathways linking supraspinal 
cardiovascular centers with the peripheral sympathetic 
outflow and lesions above T3 or more eliminate the 
normal neural cardiovascular responses to mild 
orthostatic stress.39-42 
 
2.  Low catecholamine levels  
Plasmatic catecholamine levels, both adrenaline 
and noradrenaline, are low in SCI patients, comparative to 
normal individuals. Plasma catecholamines, 
noradrenaline and adrenaline levels,  are abnormally low 
in the supine position in both the recent and chronic 
SCI.7,25,32,43-46 They do not rise, the way they do in normal 
individuals, in response to an orthostatic posture or head-
upright tilting.7,25,43-46 This is particularly pronounced in 
high-level, cervical and high thoracic, complete SCI.7 This 
is a marker of failure of sympathetic activity in response to 
orthostatism or  head-upright tilting in the tetraplegic 
patients, probably caused by the interruption of pathways 
by which the brain normally controls the sympathetic 
outflow.46 In the recently injured tetraplegics, the bladder 
stimulation caused minimal changes in plasma 
noradrenaline and adrenaline levels.32 In the chronic 
tetraplegics similar stimulation caused marked 
hypertension, bradycardia and elevation in plasma 
noradrenaline but not adrenaline levels.32,47 
The elevation in plasma noradrenaline in chronic 
SCI is caused by a reflex sympathetic discharge from the 
isolated spinal cord. This response is free of inhibitory 
impulses from supraspinal center and baroreceptor 
reflexes, either of which might restrain the increase in 
blood pressure.47 
 
3.  Rennin-angiotensin-aldosteron system 
The patients with tetraplegia rely on the renin-
angiotensin system for orthostatic blood pressure control. 
In patients with SCI, the plasmatic rennin activity 
is higher than normal. Plus, rennin levels rise rapidly and 
much higher in orthostatic posture or head-up tilt, than in 
normal individuals.7,46 Rennin release during head-up tilt 
occur independently of sympathetic nervous activity, and 
depends on the activation of renal baroreceptors.44,46  
Due to the elevation in plasma rennin activity, 
there is a late rise in plasma aldosterone.46  
 
4.  Peripheral alpha-adrenoceptor 
hyperresponsiveness  
As a compensatory mechanism for the 
decreased levels of cathecolamines, a peripheral alpha-
adrenoceptor hyperresponsiveness below the injury site 
appears.48 The hyperresponsiveness may be a 
consequence of alpha-adrenoceptor hypersensitivity or a 
failure of presynaptic reuptake of norepinephine at the 
receptor level.37  
Peripheral hypersensitivity of alpha-
adrenoceptors is responsible for the excessive pressor 
response during autonomic dysreflexia in patients with 
high spinal cord injury, and may also contribute to 
decreased blood flow in the peripheral microcirculation, 
potentially increasing susceptibility to pressure 
sores.37,48,49 
In tetraplegic patients following a recent SCI, 
intravenous infusion of norepinephine  resulted in the 
elevation in blood pressure higher than normal in normal 
individuals, probably because of peripheral alpha-
adrenoceptor hyperresponsiveness.32 
 
5. Impaired function of baroreceptors 
Baroreceptors located in the aortic arch, carotid 
sinus and coronary arteries are involved in the 
maintenance of blood pressure homeostasis. 
Baroreceptors detect changes in the arterial pressure and 
reflex modulate sympathetic and parasympathetic outflow. 
The impairment in baroreceptor reflex control is 
encountered particularly in patients with high-level, 
cervical and high thoracic, injuries, and causes low resting 
supine blood pressure in SCI individuals.25 
In addition, the circadian rhythms of blood 
pressure control, including the circulating plasma 
noradrenaline and cortisol, are abolished in individuals 
with tetraplegia, and thus high-level lesions.7,50 This 
further highlights the baroreflex dysfunction in high-level 
SCI.  
Baroreceptor sensitivity, assessed by using 
spectral analysis of variability in the heart rate period, RR 
interval on electrocardiograph, and systolic blood 
pressure, during orthostatic posture is abnormal in SCI 
patients with lesions above T3.39 Baroreceptor sensitivity 
increases with postural shift in SCI above T3, and it 
decreases insignificantly in SCI below T3.39 This 
mechanism contributes to the high-level injury orthostatic 
hypotension, above T3.  
Besides, tetraplegic patients have impaired 
baroreceptor responses to discrete stimulation of the 
carotid sinus by using neck suction or neck pressure, 
whereby both the baroreceptor sensitivity and the range 
of operation were reduced.51 
Patients sitting in wheel chairs have a chronic 
loss of stimulation of carotid sinus baroreceptors by 
routine standing posture. This is associated with 
diminished sensitivity and reduced buffer capacity of the 
arterial baroreflex and hypotension.51 Some authors 
believe that impairment in baroreceptor control is not 
found exclusively in patients harboring high-level lesions. 
By using spectral analyses, they demonstrate that 
paraplegic patients are also prone to orthostatic 
hypotension. Paraplegic patients also have altered 
baroreceptor responses to orthostasism and head-upright 
tilting, whereby the sympathetic response is blunted, and 
the response of vagal withdrawal was enhanced.52 So, the 
impairment of the baroreceptor control, encountered in Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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both high- and low-level lesions, contributes to orthostatic 
intolerance in SCI.  
 
6.  Hyponatremia and low plasmatic volume 
The plasma volume is directly dependent on the 
orthostatic tolerance and postural blood pressure 
homeostasis.7  
In both acute and chronic SCI, hyponatremia is 
frequently found.7,53 The etiology of hyponatremia is 
multifactorial. Patients have an increased ADH secretion 
that causes high sodium excretion, decreased renal water 
excretion, due to both the intrarenal and the arginine 
vasopressin dependent mechanisms. All these, coupled 
with habitually increased fluid intake, and the ingestion of 
a low salt diet and general factors such as the use of 
diuretics and the intravenous infusion of hypotonic fluids, 
lead to secondary hyponatremia and low plasma 
volume.7,53  
 
7.  Cardiovascular deconditioning 
Cardiovascular deconditioning appears as a 
consequence of prolonged bed rest and it is a loss of 
orthostatic tolerance thought to be related to diminished 
blood volume, decreased muscle or tissue pressure in the 
extremities or to functional alterations in the sympathetic 
nervous system.54 The cardiovascular decondition is 
associated with the altered nitric oxide metabolism.7,55,56  
The altered nitric oxide metabolism causes peripheral 
vasodilatation, reduces blood pressure, and cerebral 
vasoconstriction. Increased release of nitric oxide and 
upregulation of nitric oxide synthase is associated with 
orthostatic intolerance after prolonged bed rest.56  
Cardiovascular deconditioning is encountered in 
the acute phase, and its incidence is diminished with the 
progression to the chronic phase, due to the mobilization 
of the patient.  
 
8.  Morphologic changes into sympathetic neurons  
Following SCI, atrophy of sympathetic 
preganglionic neurons occurs, possibly due to partial 
deafferentation from the loss of descending medullary 
input and subsequently axonal sprouting.  
 
9.  Plasticity within spinal circuits 
Atrophy of sympathetic preganglionic neurons, 
axonal sprouting and synaptic reorganization may result 
in possible formation of new and often inappropriate 
synaptic connections.17 
Spinal reflexes and veno-arteriolar reflexes 
contribute to the improvement of the arterial hypotension 
in time.25  
In complete chronic SCI, as a response to 
noxious stimuli, like a cold pressor test, consisting of the 
immersion of the foot in ice water for 3 minutes, a reflex 
sympathetic discharged from the isolated spinal cord 
results in a significant rise in arterial blood pressure, 
higher than that in healthy subjects. This response is free 
of inhibitory impulses from supraspinal center and 
baroreceptor reflexes, either of which might restrain the 
increase in blood pressure.47  
There is not enough data to prove that the 
deafferented spinal cord could generate significant basal 
sympathetic activity.17 
 
10.  Motor deficit leading to loss of skeletal muscle 
pumping activity 
A possible mechanism producing orthostatic 
hypotension in SCI is the failure of skeletal muscle pumps 
in paralyzed limbs during postural challenge.7 The 
absence of skeletal muscle contractions during postural 
challenge has a powerful effect upon the orthostatic 
changes in blood pressure.7 
In normal individuals in standing position, 
postural muscles contractions compress veins and pump 
blood back to the heart. This is an important way of 
maintaining venous return in orthostatism. Motor deficit 
leads to lack of skeletal muscle pumping effect. That 
would predispose the patient to circulatory hypokinesis by 
reducing the venous return in the upright position and 
thus lowering the stroke volume, cardiac output and blood 
pressure.7,57,58 
The electrical stimulation of the skeletal leg 
muscles in paraplegic and tetraplegic patients induces 
muscular contractions, simulating the skeletal muscle 
pumping effect normally present in healthy individuals 
while standing. Electrically stimulated leg muscle 
contractions increased peripheral resistance, and blunted 
the fall in stroke volume that normally occurs during 
orthostasis.7 The significant deceasing in the systolic 
blood pressure, the diastolic blood pressure and the mean 
arterial pressure are noted in SCI patients. Functional 
electric stimulation during the changing position from 
sitting to standing prevents orthostatic hypotension in SCI 
patients.58,59 During the standing position it had equal or 
even greater effect on improving the blood circulation 
when compared with voluntary activation in healthy 
individuals.58,59 The use of functional electric stimulation 
during standing and tilting in SCI patients may prevent 
orthostatic hypotension and circulatory hypokinesis and 
improve tolerance to tilting and standing.58,59 
 
Deep vein thrombosis   
The risk of developing deep vein thrombosis is 
highest in 7 to 10 days after the injury and during the early 
phases of recovery and rehabilitation. The risk diminishes 
in 8-12 weeks.6  
Blood flux diminishes with 50-67% in inferior 
limbs following SCI, due to the loss of the autonomic 
nervous system control and to the reduction of the local 
blood flow.6  
Factors contributing to deep venous thrombosis 
occurrence are venous stasis in inferior limbs, secondary 
to muscle paralysis and lack of muscle pump activity, Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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venodilation, pressure on the calves and 
hypercoagulability secondary to the reduction of fibrinolitic 
activity and rising activity of factor VIII. Changes in the 
normal neurologic control of the blood vessels can result 
in stasis or sludging of the blood. 
Signs and symptoms of deep vein thrombosis 
are leg swelling, vein dilation, increased skin temperature, 
pain, tenderness, and, rarely, a bluish discoloration of the 
lower leg. Deep vein thrombosis can be present without 
any signs or symptoms.  
Thigh deep vein thromboses are a great 
concern, because the thrombi can dislodge and pass 
through the vascular tree to the lungs, causing pulmonary 
embolism, a potentially severe complication of SCI. The 
major pulmonary embolism has a high mortality 
rate. There are also no characteristic signs or symptoms 
of lung clots, signs and symptoms are nonspecific, such 
as fever, chest pain, cough, or changes in heart rate. 
 
C.  Vascular dysfunctions during the chronic phase 
of SCI 
The resolution of the acute phase merges with 
the appearance of hyperactive spinal reflexes, and spastic 
motor paralysis below the level of injury.20 The chronic 
phase of SCI is characterized by motor and sensory 
deficit, spasticity hyperactive deep tendon reflexes, 
plantar cutaneous reflex in extension and impairment of 
gastrointestinal and genitourinary tracts.17 
 
Autonomic dysreflexia 
Autonomic dysreflexia, first observed by Anthony 
Bowlby in 1890, and described by Guttmann and 
Whitteridge in 194711, is the consequence of the 
interruption of control of the sympathetic spinal cord 
centers by central nervous centers, and it is a syndrome 
of massive imbalanced reflex sympathetic discharge to 
stimuli acting below the level of injury. Distension, 
stimulation or manipulation of bladder or bowel are 
frequently determinant factors.11,27,30,60 
 Autonomic dysreflexia is frequently encountered 
in cervical injuries. The prevalence of this phenomenon 
varies between 48 and 90% of SCI above T6.11-13 Some 
incidence has been reported in SCI as low as T10.11 
Morbidity is associated with hypertension, which can 
cause retinal, subarachnoid or intracerebral hemorrhage, 
myocardial infarction, pulmonary edema or seizures. 
Mortality is rare.11 Autonomic dysreflexia is characteristic 
for the chronic phase, but it may occur any time following 
SCI. In 5.2% cases, it appears before, within the first 
month from SCI.7,61,62  
After the spinal shock resolution, the 
deafferented spinal cord, in SCI above T6, may generate 
aberrant impulses to noxious stimuli, leading to autonomic 
dysreflexia, a life-threatening complication of SCI. 
Autonomic dysreflexia is a syndrome of reflex sympathetic 
discharge from the preganglionic neurons in the 
thoracolumbar spinal cord, occurring in patients with SCI 
located above the splanchnic sympathetic outflow T5-T6, 
often triggered by the distension of pelvic viscera. 
Autonomic dysreflexia is a consequence of supraspinal 
control loss of sympathetic spinal cord neurons and 
altered glutamatergic neurotransmission within the spinal 
cord.17 The viscerosensitive impulses, below the level of 
injury, are transmitted through intact peripheral sensory 
nerves, through ascendant pathways to neurons located 
within the intermediolateral thoracolumbar nuclei, 
releasing a sympathetic reflex. Sympathetic 
hyperstimulation discharge high quantities of 
norepinephrine, dopamin-β-hydroxilasis and dopamine, 
which lead to massive vasoconstriction within arterial 
system, arterial hypertension, and cerebral vasodilatation. 
The brain perceives the hypertensive crisis throughout 
cervical baroreceptors and IX and X nerves. It generates 
inhibitory impulses that cannot be transmitted below the 
level of injury. Vasomotor centers from the medulla 
oblongata try to lower the arterial blood pressure, by 
parasympathetic stimulation of the heart, through X nerve, 
generating severe bradycardia. 
The development of autonomic dysreflexia is 
correlated with aberrant sprouting of peptidergic afferent 
fibers into the spinal cord below the injury. Sprouting of 
nerve growth factor-responsive afferent fibers has been 
shown to have a major influence on dysreflexia, perhaps 
by amplifying the activation of the disinhibited sympathetic 
neurons.63 
Peripheral alpha-adrenoreceptor 
hyperresponsiveness following SCI may play a significant 
role in the development of autonomic dysreflexia.7 
There is a constellation of signs and symptoms 
in SCI above T5-T6 in response to noxious or nonnoxious 
stimuli below the injury level, including severe arterial 
hypertension, headache and visual impairment due to 
cerebral vasodilatation, cutaneous pallor below the injury 
site, piloerection, secondary to sympathetic activity, reflex 
bradycardia, profuse sweating and cutaneous 
vasodilatation above the level of lesion, secondary to 
parasympathetic activity. Arterial blood pressure can 
reach up to 300 mmHg, leading to retinal, intracerebral, or 
subarachnoid hemorrhage, pulmonary edema, myocardial 
infarction, seizures, confusion and death.30,64  
According to the increased blood pressure, there 
are three severity grades:  
1.  mild/partial: blood pressure increases < 40 
mmHg 
2.  moderate: blood pressure increases > 40 mmHg, 
but systolic blood pressure is < 180 mmHg 
3.  severe: systolic blood pressure increases > 180 
mmHg 
 
Coronary heart disease and systemic 
atherosclerosis  
Abnormal lipid profile, with an increase in total 
cholesterol and low-density lipoprotein (LDL-cholesterol) Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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levels and diminishing of the high-density lipoprotein 
(HDL-cholesterol) level occur in chronic SCI and lead to a 
high risk of developing coronary heart disease and 
systemic atherosclerosis. The reason for diminishing the 
HDL-cholesterol is still on debate. It is assumed that it is 
due to an inappropriate diet, adrenergic dysfunction and 
lack of physical activity.6 The ratio of total 
cholesterol/HDL-cholesterol >5 is considered of high risk 
for coronary heart disease.6 Goals for optimal cholesterol 
management currently include an LDL-cholesterol level of 
< 100 mg/dl, and total cholesterol of < 200 mg/dl.6  
Treatment 
Treatment of neurogenic shock 
The treatment of neurogenic shock implies the 
correction of the arterial hypotension and bradycardia. 
Treatment of neurogenic shock is individualized for each 
patient, depending on the severity of the blood pressure 
and heart rate dysfunctions.    
The first two venous lines should be established 
for the administration of resuscitation fluids and 
medications.  
Arterial hypotension, associated with a normal 
heart rate requires volume loading, with crystalloids and 
colloids in the first 24-48 hours following SCI. In the 
absence of concomitant hypovolemic shock, Hartmann’s 
solution implies the administration of 50-100 ml per hour, 
in order to maintain a systolic blood pressure of > 80 
mmHg. Neurogenic shock associated with hypovolemic 
shock is treated with normal saline or Hartmann’s solution 
in order to increase the intravascular volume and blood 
pressure.  
Patients having arterial hypotension with arterial 
systolic blood pressure < 90 mmHg, and bradycardia with 
heart rate < 60/minute, require 0.5 mg atropine for low 
heart rate and sympathomimetics for hypotension. 
Ephedrine is a sympathomimetic drug used for the 
treatment of hypotension, and it can be given 
intravenously 5 mg or subcutaneously 25-50 mg, every 4-
6 hours.  
The heart rate of < 50/minute, nodal or 
ventricular “escape” dysarhythmias require higher doses 
of atropine administered as often as necessary up to 2 mg 
per hour.  
In severe neurogenic shock, the monitorization of 
the central venous pressure is mandatory in order to 
ensure the fluid load up to a central venous pressure of 7-
10 mmH2O. If the hemodynamic instability persists, a 
Swan Ganz catheter is assembled. It provides accurate 
information on cardiac output, heart preload and systemic 
vascular resistance. In cases of profound hemodynamic 
instability with low central venous pressure, large doses of 
vasopressors, like norepinephrine, dobutamine and 
dopamine are required. Intractable hypotension should 
raise suspicion of a concealed internal hemorrhage.  
Tissue perfusion must be maintained. 
Hypotension, consequence of neurogenic and/or 
hypovolemic shock causes spinal cord ischemia, cord 
damage and extent of neurological deficit. In tetraplegic 
patients blood pressure must be maintained ranging from 
80/40 mmHg to 100/60 mmHg. Attention should be paid 
to fluid overload that can cause cord edema, which will 
further reduce the tissue perfusion.  
 
Treatment of orthostatic hypotension  
Nonpharmacological management of orthostatic 
hypotension  
Nonpharmacologic measures should be the first 
line of therapy.65 Patients should be advised to avoid 
precipitating factors of orthostatic hypotension.65-67 
Patients must maintain the plasma volume by increasing 
the salt and fluid intake.65,66 Diuretics, like alcohol and 
caffeine must be avoided, as well as different vasodilator 
stresses such as heat stress or common vasodilators, like 
alcohol. Regular small meals minimize postprandial 
hypotension.7,65,67 Compression bandages and/or support 
stockings are useful in restricting venous pooling in the 
splanchnic region and limbs.7,67 The maintenance of the 
head position  elevated with 10-20°, during the night, 
increases plasma volume and orthostatic tolerance.68  
Patients with SCI must be told about the 
symptoms of orthostatic hypotension and they should be 
encouraged to assume a recumbent or semi recumbent 
position if they occur.65  
Pharmacological management of orthostatic 
hypotension  
The pharmacological therapy involves the 
expansion of plasma volume with fludrocortisone69 or 
increases the peripheral vasoconstriction with the alpha-
adrenergic agonist midodrine.70,71 Desmopressin acetate 
and erythropoietin are useful supplementary agents in 
patients with more refractory symptoms. 
There are rare patients who will require 
additional agents to treat their symptoms.7  
Nitric oxide synthase inhibitors are under 
investigation, and the result seems promising. They 
normalize the supine blood pressure in SCI with 
tetraplegia.56    
Associated pathology, such as type 2 diabetes 
mellitus, progressive renal and cardiovascular disease 
often requires additional treatment. Angiotensin-
converting enzyme inhibitors are often necessary for 
progressive renal and cardiovascular disease. Tetraplegic 
patients are tolerant of an acute bout of orthostatic stress 
after partial angiotensin-converting enzyme inhibitors 
administration. Although the mean arterial blood pressure, 
is reduced immediately after angiotensin-converting 
enzyme inhibitors administration, it is maintained after 
that, with increased angles of tilt and no symptoms 
occurrence.72  
 
Treatment of deep vein thrombosis 
Prophylaxis of deep vein thrombosis is 
mandatory. Nonpharmacologic prophylactic strategies Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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include the mobilization of the patient, thigh high 
compression stockings, pneumatic calf compression 
boots and physical therapy. Pharmacologic prophylactic 
treatment consists of anticoagulant therapy, such as 
heparin, low molecular weight heparin or oral 
anticoagulants.  
Heparin administered subcutaneously is useful in 
reducing blood viscosity and improving flow. Low 
molecular weight heparin has been demonstrated to be 
superior to standard heparin preparations and the former 
also significantly reduces the incidence of bleeding. 
Because of the high risk of developing deep vein 
thrombosis, in patients with SCI, regular measurement of 
bilateral calf and thigh circumferences is mandatory. 
Doppler ultrasound or venograms are frequently 
performed to establish baselines. 
If deep vein thrombosis occurs, intravenous 
heparin is administrated for 7 to 10 days. Once adequate 
anticoagulation is provided, the patient is switched to an 
oral anticoagulant therapy for 3 months. 
In patients in whom thromboembolism occurs 
under anticoagulation therapy or for patients with high risk 
to anticoagulant therapy, an inferior vena cava filter can 
be placed. 
 
Treatment of autonomic dysreflexia 
The avoidance of trigger factors prevents the 
appearance of this phenomenon. Sympatholitic drugs 
administration (alpha-adrenergic blocking agents, 
ganglionic blockers, catecholamine depleters), vasodilator 
drugs and local anesthetics can prevent the onset of this 
phenomenon.12,73,74 Oral terazosin is administrated 
prophylactically. 
The treatment of autonomic dysreflexia consists 
of an elevated position of the head and trunk and 
sublingual administration of nifedipine or nitroglycerine for 
an immediate effect. Other drugs used are 
mecamylamine, diazoxide, and phenoxybenzamine.11 The 
main therapeutic issue is the removal of the trigger 
factors, bladder and bowel decompression, because the 
persistence of the visceral stimuli maintain the 
sympathetic response.30 The analgesia is obtained by the 
administration of paracetamol or co-proxamol, aspirin or 
non-steroidal anti-inflammatory drugs being 
contraindicated.27 Unresponsive patients or the ones with 
poor response to therapy are suitable for regional or 
general anesthesia, that successfully blocks sympathetic 
response.13   
 
Treatment of dyslipidemia 
Lipid-lowering drugs are used for dyslipidemia.  
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